We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$69.4B
AUM Growth
+$2.93B
(+4.4%)
Cap. Flow
-$611M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
44.49%
Holding
2,836
New
350
Increased
1,175
Reduced
974
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$195M |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$144M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$113M |
| 4 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$83.6M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$76.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$172M |
| 2 |
Avantis US Equity ETF
AVUS
|
+$132M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$125M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$77.3M |
| 5 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.74% |
| 2 | Financials | 2.81% |
| 3 | Healthcare | 1.59% |
| 4 | Consumer Discretionary | 1.56% |
| 5 | Consumer Staples | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Douglas Elliman
DOUG
$155M
| $46.2K | ﹤0.01% |
15,612
-6,325
| -29% | -$25.2K |
|
|
BCLI
2352
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $46.2K | ﹤0.01% |
933
-779
| -46% | -$22.6K |
|
|
2353
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $45.8K | ﹤0.01% |
800
-400
| -33% | -$160K |
|
|
VLD
2354
DELISTED
Velo3D, Inc.
VLD
| $45.4K | ﹤0.01% |
571
-286
| -33% | -$25.7K |
|
2355
American Well
AMWL
$181M
| $45.4K | ﹤0.01% |
962
-5
| -0.5% | -$321 |
|
2356
Grab
GRAB
$13.5B
| $45.3K | ﹤0.01% |
15,037
-5,674
| -27% | -$18.9K |
|
2357
Karyopharm Therapeutics
KPTI
$168M
| $45.1K | ﹤0.01% |
773
| – | – |
|
|
FINV
2358
FinVolution Group
FINV
$1.12B
| $44.8K | ﹤0.01% |
10,738
-2,119
| -16% | -$10.7K |
|
|
TAST
2359
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $44.6K | ﹤0.01% |
+20,000
| New | +$40.6K |
|
|
FIRY
2360
Firy Inc
FIRY
$127M
| $44.4K | ﹤0.01% |
3,741
-82
| -2% | -$1.09K |
|
2361
Galectin Therapeutics
GALT
$229M
| $44.2K | ﹤0.01% |
21,048
| – | – |
|
2362
FuboTV Inc
FUBO
$245M
| $42.2K | ﹤0.01% |
2,908
-125
| -4% | -$2.86K |
|
|
SIEN
2363
DELISTED
Sientra, Inc.
SIEN
| $41.9K | ﹤0.01% |
27,217
| – | – |
|
|
DBD
2364
DELISTED
Diebold Nixdorf Incorporated
DBD
| $41.6K | ﹤0.01% |
34,701
-541
| -2% | -$1.2K |
|
2365
Aveanna Healthcare
AVAH
$2.06B
| $41.6K | ﹤0.01% |
40,000
| – | – |
|
2366
Grupo Aval
AVAL
$5.67B
| $40.5K | ﹤0.01% |
17,297
+6,084
| +54% | +$14.3K |
|
2367
Cardiff Oncology
CRDF
$64.3M
| $40.4K | ﹤0.01% |
24,500
| – | – |
|
2368
Eve Holding Inc Warrants
EVEX.WS
$45.1M
| $40.4K | ﹤0.01% |
+100,000
| New | +$30.2K |
|
|
HLGN
2369
DELISTED
Heliogen, Inc.
HLGN
| $39.4K | ﹤0.01% |
4,692
+298
| +7% | +$4.52K |
|
2370
Real Brokerage
REAX
$368M
| $39.3K | ﹤0.01% |
32,500
| – | – |
|
|
PSTX
2371
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $38.8K | ﹤0.01% |
12,600
+1,800
| +17% | +$10.8K |
|
|
EBET
2372
DELISTED
EBET, INC. Common Stock
EBET
| $37.6K | ﹤0.01% |
3,050
-50
| -2% | -$840 |
|
|
VXRT
2373
DELISTED
Vaxart
VXRT
| $36.9K | ﹤0.01% |
48,750
-750
| -2% | -$697 |
|
2374
Butterfly Network
BFLY
$1.72B
| $36.4K | ﹤0.01% |
19,357
-2,100
| -10% | -$4.91K |
|
2375
Companhia Siderúrgica Nacional
SID
$1.43B
| $35.1K | ﹤0.01% |
11,437
-3,051
| -21% | -$9.85K |
|
Similar funds
Creative Planning's Q1 2023 Portfolio in Review
As of Q1 2023, Creative Planning held 2,836 positions worth $69.4B, up 4.4% from $66.5B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Creative Planning's Q1 2023 filing shows 350 new, 1,175 increased, 974 reduced and 190 closed positions. Its largest new stake was GE HealthCare: 49,973 shares worth $4.1M. The largest sale was iShares Core MSCI International Developed Markets ETF, an estimated $172M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4% a quarter earlier, followed by Financials and Healthcare.
- Creative Planning's largest Q1 2023 buy was GE HealthCare: 49,973 shares worth $4.1M.
- Creative Planning added most to Vanguard Total Bond Market in Q1 2023, an estimated $195M increase.
- Creative Planning's biggest Q1 2023 reduction was iShares Core MSCI International Developed Markets ETF, cutting an estimated $172M.
- Creative Planning fully exited Signify Health, Inc. in Q1 2023, selling an estimated $1.88M.
- Creative Planning's ten largest holdings make up 44% of its $69.4B portfolio in Q1 2023.
- Creative Planning opened 350 new positions and closed 190 in Q1 2023.
- Creative Planning's portfolio value rose 4.4% quarter-over-quarter to $69.4B.
Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.